Követés
Maria Milagro Montero
Maria Milagro Montero
Jefe de Sección de Infección Nosocomial Hospital del Mar
E-mail megerősítve itt: parcdesalutmar.cat
Cím
Hivatkozott rá
Hivatkozott rá
Év
Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections
JP Horcajada, M Montero, A Oliver, L Sorlí, S Luque, S Gómez-Zorrilla, ...
Clinical microbiology reviews 32 (4), 10.1128/cmr. 00031-19, 2019
6532019
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ...
Clinical Microbiology and Infection 26 (11), 1525-1536, 2020
3572020
Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors
C Jericó, H Knobel, M Montero, J Ordoñez-Llanos, A Guelar, JL Gimeno, ...
Diabetes care 28 (1), 132-137, 2005
2932005
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
L Sorlí, S Luque, S Grau, N Berenguer, C Segura, MM Montero, ...
BMC infectious diseases 13, 1-9, 2013
2482013
Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition
E Morales, F Cots, M Sala, M Comas, F Belvis, M Riu, M Salvadó, S Grau, ...
BMC health services research 12, 1-8, 2012
2092012
Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain
E del Barrio-Tofiño, C López-Causapé, G Cabot, A Rivera, N Benito, ...
Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 01589-17, 2017
1552017
Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial
J Villar-García, JJ Hernández, R Güerri-Fernández, A González, E Lerma, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (3), 256-263, 2015
1522015
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
G Peralta, M Lamelo, P Álvarez-García, M Velasco, A Delgado, ...
BMC infectious diseases 12, 1-7, 2012
1352012
Hypertension in HIV-infected patients: prevalence and related factors
C Jericó, H Knobel, M Montero, ML Sorli, A Guelar, JL Gimeno, P Saballs, ...
American journal of hypertension 18 (11), 1396-1401, 2005
1242005
Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
M Montero, JP Horcajada, L Sorli, F Alvarez-Lerma, S Grau, M Riu, ...
Infection 37, 461-465, 2009
1142009
Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections
S Aguilar-Duran, JP Horcajada, L Sorlí, M Montero, M Salvadó, S Grau, ...
Journal of Infection 64 (5), 478-483, 2012
1032012
Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study
V Falcó, M Olmo, SV del Saz, A Guelar, JR Santos, M Gutiérrez, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 49 (1), 26-31, 2008
1032008
Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM)
H Knobel, C Jericó, M Montero, ML Sorli, M Velat, A Guelar, P Saballs, ...
AIDS patient care and STDs 21 (7), 452-457, 2007
922007
Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study
E Esteve-Palau, G Solande, F Sánchez, L Sorlí, M Montero, R Güerri, ...
Journal of Infection 71 (6), 667-674, 2015
892015
COVID‐19 in elderly kidney transplant recipients
M Crespo, MJ Pérez‐Sáez, D Redondo‐Pachón, L Llinàs‐Mallol, ...
American Journal of Transplantation 20 (10), 2883-2889, 2020
842020
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
O Gasch, M Camoez, MA Domínguez, B Padilla, V Pintado, B Almirante, ...
Journal of Antimicrobial Chemotherapy 69 (2), 568-571, 2014
832014
Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study
F López‐Medrano, M Fernández‐Ruiz, JT Silva, PL Carver, C van Delden, ...
American Journal of Transplantation 16 (11), 3220-3234, 2016
81*2016
Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and …
J Rodríguez-Baño, JM Cisneros, N Cobos-Trigueros, G Fresco, ...
Enfermedades infecciosas y microbiologia clinica 33 (5), 337. e1-337. e21, 2015
752015
Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients
M Crespo, S Collado, M Mir, H Cao, F Barbosa, C Serra, C Hidalgo, ...
Clinical Journal of the American Society of Nephrology 6 (9), 2208-2214, 2011
732011
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
M Pujol, JM Miró, E Shaw, JM Aguado, R San-Juan, M Puig-Asensio, ...
Clinical Infectious Diseases 72 (9), 1517-1525, 2021
712021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20